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This review is focused on the present status of X-ray crystallogra-
phy and its impact on chemistry and the life sciences. The discov-
ery of the DNA double-helix structure from a fibre X-ray diagram
in 1953 marked the last century, whereas the human genome pro-
ject (to be completed in the year 2003, the 50-th anniversary of
Crick's and Watson's discovery) and the proteomics will open the
new millennium. The crystal structure determinations of very com-
plex biological assemblies such as viruses and ribosomes illustrate
the power of contemporary X-ray structure analysis. The historical
background is given, which touches on some of the important steps
from the early days of the discovery of X-rays. The advanced and
new methods and technologies of the modern era, such as third-ge-
neration synchrotrons, sensitive area detectors, up-to date compu-
ter technologies with computer graphics, cryo-techniques, micro-
crystallization methods, and genetic engineering, all contributing
to the development of X-ray crystallography, are evaluated in sepa-
rate paragraphs. Some examples that illustrate the power of the
methods are selected from the contemporary research in the field.
Systematics of known crystal structures of small molecules and
macromolecules and their assemblies collected over the years has
developed our perception of the nature of the chemical bond, and
the interactions between atoms and molecules, which determine
the chemical, physical, and biological properties. This fundamental
knowledge enables structure and property predictions, useful in
many branches of science and technology. A method, starting with
the structure of table salt, has developed into a very fine tool for
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looking into complex living systems. Time-resolved crystallography
and cryo-electron microscopy are capable of recording biological
events and they inform us about the dynamics of enzymes and liv-
ing cell activities. In combination with bioinformatics, very fast
events, recorded experimentally or proposed theoretically, can be
interpreted by the methods of molecular dynamics simulations.
The vivid interplay of ideas coming from different scientific fields
and technologies has led to capital discoveries, which have opened
roads to new disciplines, such as molecular genetics and molecular
medicine. These two branches, in particular, enriched by findings
on DNA and protein structures, can provide efficient therapies for
many diseases, health prevention, and reduce ageing problems.
Our views on the nature of the chemical bond have been revised
and our horizons will be extended and clearer in the years to come.
Applying an ethical approach in science, humanity will learn how
to improve the quality of life all over the world.
Key words: review-X-ray crystallography, biocrystallography, prote-
in crystallography, synchrotron, cryo-technology, macromolecular
structures, molecular assemblies, structural chemistry, molecular
modelling.
The important thing in science is not so much
to obtain new facts as to discover new ways
of thinking about them.
W. L. Bragg
INTRODUCTION
Use of X-rays has revolutionized many branches of science, such as che-
mistry, biology, medicine, pharmacology, physics, and particularly material
sciences and a variety of technologies. This review is focused on its impact
on chemistry and the life sciences. Scattering, diffraction and absorption of
X-rays can be used for examination of small molecules, but also for proteins
and complex assemblies, such as viruses, and even living cells. X-ray struc-
ture analysis is the predominant technique for investigating molecular struc-
ture at atomic resolution in the solid state. The molecular topology in the
crystal provides insight into the interatomic and intermolecular interacti-
ons, which determine the physical, chemical, and biological properties. Let
us give a few striking examples that illustrate how X-ray structure analysis
has revealed the nature of the chemical bond. The X-ray structure analysis
of diamond, published in 1913,1 revealed tetrahedrally disposed carbon at-
oms and thus confirmed the assumption of Le Bel2 and van't Hoff 3 in the
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last decade of the 19th century. In 1891, E. Fischer and A. von Bayer4,5 em-
ployed a tetrahedral concept to understand the chemistry of sugars, which
led them to the problem of optical isomerism and conformational differen-
ces. They were able to assign the relative configurations for enantiomers of
various sugars and derivatives and their work established a new scientific
discipline – stereochemistry. In 1951 came the evidence that, by mere chance,
Fischer's assignment of glyceraldehyde was correct. J. M. Bijvoet6 dis-
covered how X-ray anomalous scattering can be used to determine the abso-
lute configuration of chiral molecules exemplified by the structure of sodium
rubidium tartrate. The Bijvoet method and Barton's principles of conforma-
tional analyses accelerated the development of stereochemistry. These find-
ings were followed by Noble prizes awarded to R. B. Woodward, D. H. R.
Barton, O. Hassel, V. Prelog, and J. W. Cornforth for stereochemistry rela-
ted research. It became clear that molecules of life, such as amino acids, su-
gars and many natural compounds, are chiral. The chiral origin of life still
remains an enigma. There are more examples that illustrate how our per-
ceptions are subject to changes. Table salt was treated as a molecule but af-
ter its X-ray analysis it turned to be a three-dimensional array of sodium
and chlorine ions held together by Coulomb interactions. In the early days
of the 20th century, it was difficult to reconcile the new view of ionic com-
pounds with the classical chemical ideas of that time. The crystal structure
of penicillin, solved by D. Hodgkin in 1949, revealed for the first time the
presence of a four-membered -lactam ring,7 unknown to organic chemists of
that time. Her determination of the vitamin B-12 structure showed the exis-
tence of a metal-carbon bond and a corrinoid ligand system, not previously
encountered in natural products.8 A completely new field of organometallic
chemistry emerged from this finding. Many examples, including myoglobin
and hemoglobin structures, can be added to the list, but the elucidation of
the DNA structure from an X-ray-fibre diagram in 19539 was undoubtedly
of paramount importance. It opened up a new era of molecular biology and
genetics, which led to the understanding of normal and pathological pro-
cesses of living cells at the molecular level. Linus Pauling, using a rational
approach to understanding the cause of sickle-cell anaemia at the molecular
level,10 envisaged molecular medicine in 1949. On the basis of X-ray struc-
tures of a wild-hemoglobin and its mutant-proteins, molecular pathology of
hemoglobin was understood. It was discovered that in sickle-cell hemoglobin
(Hbs) hydrophobic Glu6 A3(6) is replaced by hydrophobic Val residue.11,12
As a consequence the nature of interactions between two valine residues of
two subunits, a hydrophobic patch is generated and molecules aggregate in-
to long filaments. Such aggregates influence the red blood cells to distort
into sickle shape, which leads to anaemia. This is among the first examples
of understanding a disease at the molecular level. These days, molecular
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medicine turns out to be a modern discipline aimed at understanding dis-
eases, genetic anomalities, ageing problems at even the atomic level, and ac-
cordingly designing novel classes of molecules to combat illness.13 The dis-
covery of DNA structure and its genetic function and the human genome
project strongly relate molecular biology and genetics with X-ray crystallo-
graphy, enormously influencing life sciences. The human genome project14
brings many scientific excitements and benefits, but it also calls for high
ethical standards.
X-ray structure analysis has resulted in more than 250 000 known struc-
tures of small molecules and 11466 macromolecular structures (stored in
various databases such as the Cambridge Structural Database, Protein Da-
ta Bank, Nucleic Acid Database, Inorganic Crystal Structure Database, Me-
tals Data File), which are accumulating every day. They constitute rich
sources of information, which can be used in many ways.15 In addition to
simple bibliographic searches, data mining can also be employed in sophisti-
cated ways, like for structure predictions, to verify theoretical models, to de-
sign molecules of predicted properties (e.g. design of drugs and substrate
analogues for enzyme catalysts), for structural classification of proteins and
correlation with their functions.
HISTORICAL BACKGROUND
Inspired by Maxwell's theory of electromagnetic waves, W. C. Röntgen
discovered at the University of Würzburg, on November 8, 1895, a radiation
of unknown origin and properties, which he called X-rays.16 In order to ma-
ke his discovery more convincing to himself and to many others, he asked
his wife Bertha to put her hand over a film into a beam of »unknown rays«.
The shadowgraph of a hand skeleton with a golden ring taken on December
22, 1895 circulated quickly all over the world, as it did a hundred years la-
ter at its centennial anniversary. The discovery gained enormous publicity
because everybody realized the power of X-rays to reveal »the architecture
of the invisible«. The long lasting wish to see the interior of the human body
without using a scalpel became reality. The world realized the importance of
Röntgen's discovery and the first Nobel prize for physics was awarded to
him in 1901. X-rays were named röntgen radiation after him. Though scien-
tists tend to shun superlatives, H. H. Seliger17 nevertheless classified the
discovery of X-rays as the most important application of a physical phenome-
non in the history of science. The application of X-rays started only three
months after the discovery. The ability to produce a shadowgraph of the in-
ternal structure of a wide variety of animate and inanimate objects has
been extensively exploited in medicine and various technologies. Simple ra-
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diography, used by M. Curie in movable units on the battlefields during the
first world war in order to help wounded soldiers, has now developed into
sophisticated computerized tomography with digital imaging. Powerful be-
tatrons, gammatrons and mevatrons used in cancer therapy are also based
on Röntgen’s discovery. Small high-energy synchrotrons adopted by hospi-
tals are used as angiography diagnostic devices.18–20 They are among the
most advanced technologies in medicine. The early application of fluorosco-
pes for passenger control, started in France in 1897, has become common
practice at airports. Fluoroscopy became an efficient method for catching
smugglers of Egyptian mummies and archeological objects at the beginning
of the 20th century, as it still is today in detecting armed terrorists. X-ray
fluorescence analysis has developed into a powerful analytical method for
the determination of trace elements, which has found its application in min-
eralogy, geology, archeology, ecology, pollution control of soil and water, and
many other fields. Even astrophysics benefits from Röntgen’s discovery. The
world’s most powerful X-ray telescope carried by Ariane 5’s rocket was laun-
ched in December 1999 within the European Space Agency programme.21
Seventeen years after Röntgen's discovery, Max von Laue suggested that
X-rays can be diffracted or scattered by a crystal.22 The experiments per-
formed immediately after that by W. Friedrich and P. Knipping22 were
aimed at resolving the controversy over the nature of X-rays. The experi-
ments revealed its wave nature and confirmed von Laue's idea,23 for which
he won the Noble prize in 1914. A new branch of science based on this dis-
covery saw the light in November 1912 when the 22-year-old Lawrence
Bragg interpreted the complicated pattern of Laue's photograph. He applied
the very simple idea coming from the optics of visible light that X-rays are
reflected from the atomic planes in the crystal (Bragg's law).24 Together
with his father, W. H. Bragg, he built the first spectrometer,25 which enabled
the structure determination of some minerals, such as diamond and table
salt. The most striking idea in that area, put forward in 1915 by W. H.
Bragg,26 involved the representation of the periodic repeat of atomic pat-
terns in the crystal by Fourier series. This mathematical formulation was a
milestone in X-ray structure analysis. In 1915, the Nobel Committee recog-
nized the great scientific discovery of the Braggs and awarded them a prize.
According to W. L. Bragg, »the development of X-ray crystallography since
1912 has more than fulfilled our early expectations. It not only has revealed
the way atoms are arranged in many diverse forms of matter, but also has
cast a flood of light on the nature of the forces between atoms and the large-
scale properties of matter. In many cases this new knowledge has led to a
fundamental revision of ideas in other branches of science«.27 W. L. Bragg's
predictions of X-ray crystallography given in 1968 have been amply confir-
med by the determination of many complex protein structures such, as vi-
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ruses, e.g. the blue tongue virus28 and Norwalk virus,29 and the ribosome
structure.30–42 During its 88 years of developement, X-ray crystallography
has opened up new ways of studying matter, providing scientists with a very
special kind of powerful »spectacles« to see the invisible architecture of the
molecules in crystals and it has so far harvested 15 Nobel prizes. On the oc-
casion of the centennial anniversary of Röntgen’s discovery, the University
of Würzburg established a foundation for the Centennial Röntgen Award for
Life Sciences, Medicine, and Physics; the first was given to Prof. Axel T.
Brünger of the Howard Hughes Medical Institute, Yale University, for the
application of molecular dynamics simulations in the refinement of protein
structures.
FUNDAMENTALS OF X-RAY DIFFRACTION
The principles of X-ray diffraction are well established. X-ray scattering
originates from electrons (Thomson scattering). An incident wave induces
other scattering centres to produce this effect and these individual waves
interfere. The resulting scattered wave coming from the object (array of at-
oms in the crystal) depends on its internal structure, i.e. geometrical pat-
tern and the scattering power of each atom. First, consider a crystal as con-
sisting of periodically arranged building blocks (called unit cells). Because of
this periodicity, no scattering will be observed when scattered waves from
these unit cells are not exactly in phase; this is because the interference is
completely destructive. Therefore we need to consider the scattering from
the unit cell only. When a volume element at position r (defined with re-
spect to the origin of the unit cell) is irradiated by a beam that propagates
in the direction s0 (s0 = 1/), the amplitude of the scattered beam is propor-
tional to V(r) dr [(r) being the electron density at the position of vector r;
vectors are printed in bold face italic type and scalars in italic type]. In or-
der to take into account the interference with beams scattered by electron
densities at other positions, we should consider its phase (conveniently ex-
pressed with respect to the origin of the unit cell). When scattering occurs in
direction s, this phase is calculated to be 2 S · r (with S  s – s0).
The total scattering over all elements of the volume V of the unit cell,
normalised to the scattering of a free electron, takes the functional form of a
Fourier transform:
F(S) = r

(r) exp (2i S · r) dV
This represents the structure factor; it is a fundamental expression in
X-ray crystallography.
In X-ray structure analysis, the Fourier inversion is used.
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Because F(S) = F (r)
(r) = F F(S)
The crucial problem is that F(S) is a complex quantity; F(S) = F(S)eis;
it has a magnitude and a phase. We are measuring only the scattered inten-
sity, and this is proportional to F(S)2, so the phase is not accessible by the
diffraction experiment. This central problem of X-ray analysis is known as
the phase problem. To obtain the desired electron density r, whose maxima
reveal the positions of the atoms in the unit cell, the phase problem has to
be solved. Diffraction from the crystal, by its periodic nature, is restricted to
certain directions. They are subject to the so-called Laue conditions: S · a =
nh, S · b = nk, S · c = nl; h, k, l are integers, relatively prime to each other,
n is an integer factor.
Bragg derived a more manageable equation, considering diffraction as
»reflection« from a series of equidistant and equivalent planes in a lattice:
2 dhkl sin  = n 
dhkl is the distance between neighbouring lattice plans; h, k, l (identical to
the integers appearing in the Laue equations) specify the lattice planes and
are termed Miller indices, n is called the order of reflection. In diffraction, it
is common practise to absorb n in h, k, l so that the latter symbols represent
the Laue indices.  is the angle of incidence and reflection with respect to
the lattice plane.
Structure factors obtained for a large number of reflections with Laue
indices h = (h,k,l) give the desired electron density summed over all atoms
(j) in the unit cell at the positions xj, yj, zj
(r) = 1/V 
h
F(h) exp (–2i h · r) =
= 1/V 
h
F(h) exp –2i (xa + yb + zc) · (ha* + kb* + lc*)
where r = xa + yb + zc, and a*, b* and c* are the vectors of the reciprocal
lattice (mathematically defined by the relations a* · a = 1, b* · b = 1, …, a*·
b = 0, etc).
The phase problem can be tackled in two different ways: a) using vector
methods requiring a heavy atom or a sufficiently large molecular fragment
(strong scattering element) to be present in the structure, and b) application
of direct methods (based on algebraic relations combined with information
from internal crystal symmetry, and probability theory). In macromolecular
crystallography, various combinations of heavy-atom methods are used: the
single isomorphous replacement method (SIR), the multiple isomorphous
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replacement method (MIR), and the multiple wavelength anomalous dis-
persion method (MAD). We shall briefly discuss the physical base of the
anomalous effect in order to show its implications in X-ray diffraction. Elec-
trons can be treated as oscillators; if the frequency of the primary beam ap-
proaches some of their eigen frequencies, resonance will occur with a con-
comitant additional phase shift in the scattered beam. The scattering under
these conditions is considered anomalous and its contribution is added to
the normal atom scattering factor (f = fo + Df ' + if '', the last two terms being
called the real and the imaginary dispersion corrections, the values of which
depend on the wavelength and the anomalously scattering atom in the struc-
ture). One consequence of this effect is that Friedel's law is disobeyed (Fhkl 	
F–h–k–l), as discovered by Bijvoet.
6 The Bijvoet differences are wavelength
dependent and maximal at the absorption edge. Radiation of different wave-
lengths can be easily produced by synchrotrons. Thus, the departure from
this law can be used for phasing (MAD)43,44 and for the determination of the
absolute configuration of molecules.
Molecular replacement is an additional possibility for phasing, using
known structure fragments (homology search via Protein Data Bank) com-
bined with translation and rotation functions to match fragments of a
known structure with those in the unsolved structure. Non-crystallographic
symmetry for phase averaging of noncrystallograhic units can be applied
even between different crystal forms for improvement of poorly determined
phases rather than for ab initio phase determination. Rossmann and Blow
196345 initiated the method while determinating virus structures. These
days, Rossman phasing is a common practise in protein crystallography, par-
ticularly in solving virus structures.
The development of mathematical methods for obtaining the model of a
crystal structure from experimental data and the improvement of its accu-
racy have been directed towards evaluation of measured data (data reduc-
tion), solution of the phase problem, density-map interpretation, and refine-
ment of the model. Mathematical formulations and adequate algorithms are
the basic elements for software development, which has to keep pace with
the quickly advancing hardware. To illustrate the impact of computer tech-
nology, let us mention an example: in the late sixties the determination of
the structure of vitamin B-12 (C63H88N14PCo, totally 181 atoms in a mole-
cule)8 required more than eight years. Intensity evaluation was done by
naked eye, data reduction and two-dimensional Fourier syntheses were cal-
culated manually (using Beevers-Lipson strips invented in 1936, and a
somewhat advanced punch-card method). Nowadays, such a determination
would hardly take a day.
Among the mathematical formulations that have advanced crystallogra-
phic software are the fast Fourier algorithms, least-squares procedures
8 B. KOJI]-PRODI] AND J. KROON
(such as simulated annealing), various combinations of Patterson searches
(for the global shape of a molecule and its orientation, applying rotation and
translation functions and a number of combinations and modifications
thereof), and maximum entropy enhancement. There is quite a number of
software packages available for X-ray structure analysis of small and large
molecules. Great progress in the solution of complex protein structures has
been achieved with the program packages CCP4,46 AmoRe47 and CNS (a
new version of X-PLOR).48
SYMMETRY
The natural beauty of crystals, observed by the naked eye or light mi-
croscopy, derives from their symmetrical regularity, colours and brightness
(Figure 1). However, the inner symmetry of the three-dimensional pattern
within a crystal, revealed by X-ray diffraction, implies much more; it affects
the properties of all crystalline material. The inherent symmetry of a mole-
cule can also be depicted from the X-ray analysis (Figures 2a49 and 2b50). In
addition to recognising the 230 ways of periodical packing of a pattern (spa-
ce groups), X-ray structure analysis can show internal non-crystallographic
symmetry originating either from pattern irregularities or formation of mo-
lecular assemblies. In the regular crystal symmetry, there are only 1, 2, 3, 4
and 6-fold rotation axes and no five-, seven- or eight-fold rotation operations.
However, five-fold symmetry51 common in the living world (flowers, a sea-star,
spider web) has been detected in virus structures, some protein structures,
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Figure 1. A natural sample of the sulphate mineral celestite (SrSO4) from Poland,
private collection.
and also fullerene molecules. The spherical virus morphology of icosahedral
symmetry includes pentamers52 represented here by a detail of the crystal
structure of the human hepatitis B virus capsid53 solved at 3.3 Å resolution
(Figure 3). Illustrative examples of the biological function and assembly forma-
tion using seven- and eight-fold symmetry are also given. The 
-haemolysin
toxin produced by the pathogenic bacterium Staphylococcus aureus forms a
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Figure 2. X-ray structure analysis reveals the molecular symmetry: a) molecule of
As, Ge-triptycene with a three-fold symmetry axis,49 and b) 5,11,17,23-tetra-tert-bu-
tyl-26,28,25,27-tetrakis(O-methyl-R-
-phenylglycylcarbonylmethoxy)calix4 arene so-
dium perchlorate with a four-fold symmetry axis.50
a
b
heptameric pore structure (solved at 1.9 Å resolution)54 (Figures 4a and b).
The heptameric membrane associated complex inserts through the lipid
bilayers, forming transmembrane pores for rapid calcium influx, which can
induce cell lysis.55
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Figure 3. A stereo view from outside the capside of the human hepatitis B virus show-
ing the interactions between adjecent subunits with five-fold symmetry.53 Reprinted
by permission from Cell53 copyright (2000) Cell Press.
Figure 4. The 
-haemolysin heptamer at 1.9 Å resolution (each promer has been col-
oured differently): a) view perpendicular to the seven-folded axis, b) top-view along
the seven-fold axis.54 Reprinted by permission from Science54 copyright (2000), Ame-
rican Association for the Advancement of Science.
The porphobilinogen synthase family of metalloenzymes catalyzes the
first common step in the biosynthesis of tetrapyrroles such as corrins (con-
taining Co), chlorophyll (containing Mg), and porphyrin (with Fe). In the
crystal, it assembles into an octamer (Figure 5).56
For enzyme stereospecificity and the receptor-substrate complementari-
ty nature has denied life from mirror symmetry. As a consequence, crystals
containing proteins and viruses belong to space groups that do not include
inversion or mirror symmetry, which would otherwise lead to inversion of
amino acid or carbohydrate chirality.
ADVANCED AND NEW METHODS AND TECHNOLOGIES
SUPPORTING THE DEVELOPMENT OF X-RAY CRYSTALLOGRAPHY
The tremendous progress of X-ray crystallography is based on the use of
powerful computers, employed in on-line experiments such as robotic ma-
chines for crystallization experiments, controlled data collection,57,58 data
processing,59 interpretation of Fourier maps,60 refinement of an experimen-
tally derived model of the structure,48 visualization of the three-dimensional
structure and modelling using computer graphics, handling databases (data
mining) for structure systematics and predictions, and study of protein fold-
ing and structure/activity correlations.
For the determination of macromolecular structures, more intense sour-
ces of high brilliance and a high degree of collimation are required for data
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Figure 5. Yeast porphobilinogen synthase octamer.56 Reprinted by permission from
the International Union of Crystallography, Acta Crystallographica56 copyright (2000).
collection. Some improvement in this respect was made by the use of rotat-
ing anode tubes, and a significant step forward was achieved by the first ex-
ploitation of synchrotron X-ray radiation in the late seventies. The constant
progress of technology led to the third generation of synchrotrons61–66 oper-
ating at 6 GeV and above, providing crystallographers with a more intense
(many orders of magnitude in intensity than classical X-ray tubes) mono-
chromatic beam of high brilliance and collimation, suitable for very small,
weakly diffracting samples (about 50 m cross-sectional diameter) as well as
very large unit cells (such as the blue tongue virus core of 795  822  753 Å3
(Ref. 28) and the 50S ribosomal subunit of 212  301  576 Å3 (Refs. 31, 37)).
An additional experimental advantage of such sources is the wavelength tu-
neability, which makes it possible to use the method of multi wavelength
anomalous dispersion (MAD) over a wide range of atomic absorption edges
for phase determination of structure factors. By virtue of such a powerful
X-ray source it is also possible to perform time-resolved experiments, e.g.
using polychromatic radiation on stationary crystals producing Laue pat-
terns. This idea might seem paradoxical to the basic concept of X-ray crystal-
lography. In general, X-ray crystallography reveals only the space average
structure over all the molecules in the crystal for the time of exposure to the
X-ray beam. However, for time-resolved crystallography using a polychro-
matic synchrotron beam and a stationary crystal, and an exposure time
about three orders of magnitude shorter than that of a monochromatic ex-
periments, ultra-fast experiments are possible.67 In reality, a series of
events can be recorded. With a powerful source and fast detector, but also
using smart software for the interpretation of the rather complex Laue pat-
terns, it is possible to study enzymatic reactions in situ at nanosecond time
resolution.68,69 This facility induces studies of various photo-activated pro-
cesses. It is possible to use real-time in situ observations of many chemical
reactions, like oxidation processes, dimerization, hydrogen-deuterium ex-
change (using neutron diffraction) and many others.70 An example of wide
interest is the reaction dynamics of myoglobin. A nanosecond time-resolved
data set on the carbon monoxide complexes of myoglobin revealed a rupture
of the covalent bond between the iron atom of the heme and carbon monox-
ide by a nanosecond light flash.71 The carbon monoxide migrates away from
the heme, and the heme and the protein relax towards the stable deoxyhe-
moglobin structure. At room temperature, the entire reversible cycle is com-
pleted in the crystal in some hundreds of microseconds. This has been studied
by various spectroscopic methods as well. Still, a few details relating to the
dynamics of the whole process remain unclear.
There is another aspect of the application of intensive X-ray beams,
which has also been considered. In addition to nonspecific radiation damage
of the crystal that might appear at cryogenic temperatures (generally mani-
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fested as decay of intensities), there also appears to be specific radiation da-
mage. This can be related to particular chemical reactions initiated by radi-
ation. Very recent data recorded on the crystal of acetycholinesterase from
Torpedo californica (TcAChE) at 100 K using an unattenuated beam with a
wavelength of 0.93 Å (experimental details are given in Ref. 72), revealed
time-dependent changes in the electron density in the region of the disulfide
bridge between Cys 254 and Cys 265 (Figure 6). Sequential Fourier maps
clearly revealed continuously diminishing electron density with time, which
ends with complete cleavage of the Cys 254 – Cys 265 disulfide bond. Two
other disulfide bonds, Cys 402 – Cys 521 and Cys 67 – Cys 94, appeared to
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Figure 6. Difference Fourier maps of acetylcholinesterase from Torpedo californica
revealed time-dependent changes in electron density in the region of disulfide bridge
between Cys 254 – Cys 265, which end with a rupture of disulfide bond.72
be more stable over the same period of time. It was also noticed that the cat-
alytic triad residue His 440 is more sensitive to radiation damage than the
other histidine residues. Such changes should be recognized in order to be
clearly distinguished from the changes related to intrinsic enzymatic activity.
The crucial part of data collection is associated with recording diffracted
intensities. They should be measured as fast as possible (short exposure ti-
me) and be equally sensitive to weak and strong intensities (dynamic range)
over a wide space angle, having no dead time (to record promptly the inten-
sity, i.e. with near photon-counting statistics). Two alternative types of de-
tectors have been used: point detectors measuring the energy of a single re-
flection (classical detectors) and area detectors, which collect numerous
reflections on the same two dimensional device (such as films, wire detec-
tors, imaging plates, charge-coupled devices (CCDs)).73,74 Image plate (IP)
and CCD-based systems have been developed primarily for protein crystal-
lography and they reasonably meet the above requirements. Further impro-
vements for particular applications are expected. The properties of the crys-
tal (its size and unit cell dimensions) and diffraction pattern (peak to
background intensity ratio and the angular width of the diffraction featu-
res) are intrinsic to the crystal.75 Thus, experimental conditions, such as the
properties of the X-ray beam and the type of detector, should match the
sample.
Among various techniques applied for improving X-ray diffraction expe-
riments, cryo-techniques76,77 deserve to be discussed. Cooling a crystal with
liquid nitrogen or helium (down to 100 K and 3–5 K, respectively) during in-
tensity measurements significantly improves the quality of the experimen-
tal data, but also makes it possible to obtain data of thermally unstable or
air-sensitive samples. Freezing of the sample considerably reduces radiation
damage and also prevents crystal slippage from the fixed position on the go-
niometer-head during intensity measurements. Flash-cooling to near 100 K
extends the crystal life-time, even during measurements in the synchrotron
beam, and contributes to better resolution of the data. By cooling the sam-
ple, thermal vibrations of atoms in the crystal are reduced (electron density
becomes more concentrated) and thus the ratio between peak intensity and
background increases (better signal to noise ratio). As a consequence, it is
much easier to locate the atoms in a Fourier map. In crystals with transla-
tional defects, it is possible to discriminate between static and dynamic dis-
orders. Dynamic disorder is reduced by cooling, whereas static disorder is
not significantly affected, unless there is a phase transition. Cryo-techniques
are also inevitable for studying phase transitions for various compounds of
interest in material sciences. For such purposes, cooling with liquid helium
is essential if phase transitions can be expected below 100 K.
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During the last eight years, the use of cryo-techniques in macromolecu-
lar crystallography has significantly improved the quality of intensity data
and makes it possible to work with very sensitive proteins. Specially manu-
factured tools for selecting and mounting a micro-dimensional sample in a
drop of cryoprotectant liquid supported by a fibre loop sitting on the top of a
pin holder at the goniometer-head are for sale, but the »green-fingers« needed
to mount a crystal properly are not commercially available.
To produce a good diffracting crystal requires even more knowledge and
skills. The first protein crystals produced 150 years ago were of hemoglobin
and the first X-ray diagram of a protein (pepsin) was recorded by D. Hodg-
kin and J. D. Bernal in 1934.78 Twenty years ago, crystallization was treat-
ed as art rather than science, but in the last decade it has been a quickly
developing branch of science, based on a large number of experiments, some
of them being performed in space shuttles to eliminate the influence of gravi-
tation on crystal growth. Indeed, microgravity experiments often produce
crystals diffracting at higher resolution. Diffraction experiments performed
on samples of insulin crystals grown under earth and microgravity condi-
tions revealed a significant difference in quality. The reflection profiles of
earth-grown crystals showed multiple gaussian shapes and were 0.060–
0.100 degrees wide at the FWHM. Microgravity crystals were perfect, with
single gaussian profiles and FWHM width of only 0.002–0.006 degrees.79
The preparation of crystals involves nucleation and growth. When experi-
mentators realized that these processes were governed by the same physico-
chemical rules for small and large molecules, considerable improvements
were made. More than twenty microtechniques were invented. Among the
most common are vapour diffusion, liquid diffusion, and dialysis.80,81 All of
these methods explore the protein solution, searching for conditions that in-
crease the degree of saturation to the stage where protein-protein interac-
tions become adequate for initial nucleation. It is important to find the most
suitable technique and optimize all experimental conditions, which are pro-
tein and method dependent. Thus, special screening procedures according to
experimentally established protocols (stored in the biomacromolecular crys-
tallization database)82,83 can be applied. In order to screen the enormous
numbers of experimental parameters, robotic machines have also been de-
signed. Generally, these experiments take care of the purity of the prepara-
tion, concentration of the protein, concentration and type of the precipitant
(which reduces the solubility of the protein), pH, temperature, selection of
buffer and additives (salts, organic components, and detergents) in low con-
centrations. A typical experiment can be run in a solution volume of 2–4 L,
although there are experiments with droplets of 1–2 L. For a »macroscopic«
crystal suitable for X-ray analysis, about 7–15 g of protein is needed. Even
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commercially available screening protocols such as Wizard-I84 cannot solve
all problems. In order to succeed in growing good quality crystals, one has to
know as much as possible about the protein characteristics. A reasonable
amount of substance should be provided to complete the biochemical charac-
terization and to crystallize the protein of interest. Usually, proteins from
natural sources are not available in amounts larger than a few mg.
Methods of molecular genetics support tremendously the development of
X-ray structure analysis of macromolecules, with recombinant DNA tech-
niques being used for cloning and expressing proteins of interest in tens of
milligrams. However, there are more aspects of genetic engineering that are
useful for protein crystallography. Once an initial protein structure is
known, understanding its function is the final goal of the research. By site-
directed mutagenesis of specified amino acid(s) responsible for interactions,
functional hypotheses can be tested. This procedure is common practice for
almost each new protein studied.
This technique makes it also possible to substitute sulphur with sele-
nium (as an attractive anomalous scatterer of X-rays) in methionines, which
then serve as a phasing label in the experimental phasing of structure fac-
tors by multiple anomalous dispersion (MAD method), using variable wave-
lengths in synchrotron experiments.85,86 Using this method, preparation of
several heavy-atom derivatives and the subsequent data collection can be
avoided. This is not only a more sophisticated approach, but it also prevents
possible protein destruction by the incorporated metal atoms. According to
the evidence87 about 40% of new protein structures are being determined by
the MAD phasing method. For the structures solved by synchrotron radia-
tion, MAD phasing exceeds 70% (very often using SeMet phase label).
HIGHLIGHTS OF (BIO)CRYSTALLOGRAPHY
Revision of various aspects of chemical bonding relies very much on
charge density studies applied in chemistry, biology, and solid-state phys-
ics.88–90 X-ray analysis performed for charge-density studies differs some-
what from the conventional structure determination in its theoretical con-
cept. Technical developments (already discussed in the previous paragraph)
enable high accuracy of data collection, and advanced software, specifically
designed least-squares procedures (based on an aspherical atom model),
provide very precise electron density maps. Use of low temperature (< 20 K)
experiments reduces the thermal vibrations of the atoms in the sample with
their detrimental obscuring effects on electron density maps. The electron
maps obtained using such data treatment reveal fine details about the elec-
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tronic structure and its modifications, influenced by partners connected by
the chemical bond or participating in intermolecular interactions. As the
method stands today, such fine details match perfectly the pictures obtained
by theoretical ab initio calculations. Charge-density studies can reveal over-
lap between atomic orbitals, lone pairs, the bending of bonds in strained
rings,  bonding, polarization effects, deformation of electron density in in-
termolecular interactions, particularly in hydrogen bonds. Due to the high
chemical and biological relevance of the properties of sulphur – sulphur in-
teractions, the charge density study of hexagonal L-cystine91 is selected to
illustrate the achievements of the method. The deformation density distri-
bution and topological analysis of charge density reveals that the S–S bond
of disulfide bridge is a weak single covalent bond (Figure 7).91,92 The valence
shell charge concentration suggests sp3 hybridization of sulphur atom. The
analysis also reveals hydrogen bonds via COO– and NH3
+ (Figure 8)91,93
which contribute dominantly in the dipolar moment.
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Figure 7. 

, (r) gradient vector field of the electron density of L-cystine in the plane
containing the SS bonds.91 SSB bond is along the 0 1 0 direction. The 

, (r) was
calculated from the NEWPROP Program.92 A disulfide bridge occurs between two
cystine molecules connected by a two-fold axis parallel to [1 0 0] or [1 1 0] (SSA =
2.0472(4) Å). The SSB (SB: x, 1+x–y, 1/6–z) intermolecular contact found in L-
cystine (3.4264(4) Å) is much shorter than the sum of Van der Waals radii (3.7 Å).
The picture was obtained from Prof. dr. C. Lecomte.
Understanding the nature of non-covalent interactions is essential for
reaching the secrets of molecular aggregation in the biotic world, but also in
synthetic chemistry which has now expanded into the fascinating field of
supramolecular chemistry.94,95 An important step in the process of aggrega-
tion is molecular recognition, which is based on chemical and geometrical
complementarity between interacting molecules. One can design a supramo-
lecular synthon, a small molecule provided with a particular functionality
suitable for intermolecular interactions, e.g. containing points of recognition
such as proton-donor and proton-acceptor sites, which form infinite connec-
tions of one-, two- or three-dimensional arrays of hydrogen bonds. An illus-
trative example is a discrete spherical supramolecule of icosahedral symme-
try, composed of six calix4 resorcinarenes and eight water molecules
connected by sixty hydrogen bonds with a well-defined cavity of 1373 Å3 (Fi-
gure 9), which can encapsulate various guest molecules.96 Such types of su-
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Figure 8. Electrostatic potential in the plane of the COO– group of the isolated L-cy-
stine molecule. Contours intervals are at 0.05 e Å–1; solid lines are positive. Dotted
line are negative, and zero contour is a broken line (ELECTROS Program).93 This
map gives the electrostatic potential generated by the L-cystine molecule removed
from its crystal lattice in its carboxyl plane. The oxygen atoms are surrounded in the
outer region by a wide and deep negative region (–0.30 e Å–1; 1 e Å–1 = 332 kcal
mol–1 = 1390 kJ mol–1), which would favor the approach of electrophilic agents as
well as hydrogen bonds.91 The picture was obtained from Prof. dr. C. Lecomte.
pramolecules of adjusted lipophilicity can imitate biological vesicles, and
some of them might be used for controlled release of encapsulated drugs
into body fluids. In general, supramolecules of spherical and tubular mor-
phologies have potential fundamental and practical implications; through
nanotechnology they are related to material science, biomimetic chemistry,
and molecular electronics. The topology of such molecules (Figure 10)97 is
very close to that of the spherical polyhedral shells of the capsids of the blue
tongue virus,28 simian virus 40,98 human hepatitis B virus (Figure 11),53 reo-
virus99 or tubular protein coats of viruses, and fullerene molecules,100 which
also involve covalent interactions. In spherical viruses, capsids with icosa-
hedral symmetry would provide the most compact protein assembly, serving
as a protective coat around the nucleic acids. Capsids with strict icosahedral
symmetry would allow a maximum of sixty chemically identical subunits.
However, it has been known from the structures of numerous spherical vi-
ruses that the number of coat proteins significantly exceeds 60. For exam-
ple, in simian virus 40 (polyoma virus),98 including a double-stranded DNA
genome, there are 360 copies of the major structural protein, arranged as 72
pentameric building blocks on the viral surface. The subunits also contain
two more proteins. In order to illustrate the complexity of the virus struc-
tures and the advances made, both scientific and technical ones, the biggest
virus core structure so far known, of the blue tongue virus is briefly descri-
bed.28,101 The BTV particle (Figure 12) (54 MDa) contains 780 copies of a
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Figure 9. A chiral spherical molecular assembly of six calix[4]resorcinarenes and
eight water molecules along a three-fold axis with topology similar to spherical vi-
ruses.95 Reprinted by permission from Nature95 copyright (2000) Macmillan Maga-
zines Ltd.
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Figure 10. Spherical arrangement with a pseudo five-fold symmetry of amphiphilic
p-sulphonato calix[4]arene building blocks with the geometry similar to a spherically
shaped coat of virus.97 Reprinted by permission from Science97 copyright (2000),
American Association for the Advancement of Science.
Figure 11. The capsid of the human hepatitis B virus revealing an icosahedral sym-
metry.53 Reprinted by permission from Cell53 copyright (2000) Cell Press.
VP7 (T13) protein subunit (38 kDa) arranged as basic trimers (assembling
into hexamers and pentamers) on a T13 (T corresponding to the number of
proteins in the icosahedral asymmetric unit) quasi-equivalent lattice, which
form the core surface. This VP7 (T13) subunit of the outer layer covers a
subcore shell constructed of 120 copies of the VP3 (T2) protein (100 kDa).
The VP3 (T2) molecules bind RNA. The core also includes some enzymati-
cally active proteins and ten double-stranded segments of (ds) RNA (about
19 000 base pairs). Thus, the icosahedral building block is composed of 13
subunits of VP7 (T13) attached to two molecules of VP3 (T2). To collect 21
million intensities, about 1000 crystals had to be used (due to radiation da-
mage occurring also at cryogenic temperatures). The set of unique data of
about 3.3 million was used in Fourier syntheses and refinement. 49 000 at-
oms were located within an icosahedral asymmetric unit while the entire
BTV particle contains 2.9 million atoms. The elucidation of this structure
depended on many creative steps, among which was electron density aver-
aging (already described in the section Fundamentals of X-ray Diffraction)
over non-crystallographic 30-fold symmetry. There is also the fundamental
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Figure 12. The architecture of the blue tongue virus (BTV) core: a) the icosahedral
asymmetric unit contains 13 copies of VP7 (T13) arranged as 5 trimers, P, Q, R, S,
and T (coloured red, orange, green, yellow, and blue, respectively), and b) the VP3
(T2) scafold with icosahedrally unique molecules A (green) and B (red), having a struc-
turally different environment. The two-fold, three-fold and five-fold symmetry axes
are marked.28 Reprinted by permission from Nature28 copyright (2000) Macmillan
Magazines Ltd.
question relating to the biological function of the virus. How does Nature ef-
ficiently organize such a »living polyhedron«? This is realized by reducing
exact symmetry to an approximate one; the subunits in clusters are quasi-
equivalent. Such associations are sufficiently flexible to accommodate dis-
tortions and a higher number of subunits can be built in.52 Grimes and co-
workers28 took the challenge to explain the nucleation of such a large as-
sembly. It is remarkable that the self-assembly mechanism of primitive bio-
logical entities (viruses), according to Klug, resembles the nucleation and
growth of a crystal lattice.
»The crystal is, in a sense, the supramolecule par excellence: a lump of a
matter, of macroscopic dimensions, millions of molecules long, held together
in a periodic arrangement by just the same kind of noncovalent bonding in-
teractions as are responsible for molecular recognition and complexation at
all level.«102 Even more, the crystallization process itself exhibits supramo-
lecular assembly. Thus, crystal packing patterns with their infinite motifs
represent aggregations of supramolecular types. It is very important to re-
member that the properties of a synthon (a single molecule) are different
from those of its supramolecular aggregates. This approach is the basic con-
cept of crystal engineering, which is also useful in generating molecules for
nanotechnologies.
Molecular nanotechnology draws on cutting-edge advances in physics,
chemistry, biology, and computer science to build structures measured in na-
nometers. Its start and development is based on the very simple statement
made by R. Feynman, Nobel laureate in physics (for quantum electrodyna-
mics). »The principles of physics, as far as I can see, do not speak against
the possibility of manoeuvring things atom by atom.« Nature leaves us to
learn how to arrange atoms the way we want and to develop molecular manu-
facturing. The properties of products obtained depend on how the atoms are
arranged. A very simple example: if we rearrange the atoms in coal, we can
make diamond. Thus, we are not far from the dreams of medieval alchemists.
Very sophisticated maneuvering is based on DNA self-assembled molecules
created by human mind and hands. N. Seeman and coworkers103–107 created
DNA molecules whose helix axes have the connectivities of a cube and of a
truncated octahedron (Figure 13)108 and DNA knots. For developing ways to
construct three-dimensional objects, including cubes and more complex poly-
hedra, from synthetic DNA molecules, N. Seeman won the 1995 Feynman
Prize in Nanotechnology. The periodic arrays (crystals) of DNA objects could
be used to direct the assembly of biochip computers. But the list of applica-
tion is wider. By developing DNA assemblies experimentalists aim to con-
struct mini-biorobots for monitoring, repair, construction and control of the
human biological system at the molecular level (nanomedicine).
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Crystallographers have a very direct interest in synthesizing periodic
matter in a rational fashion in order to avoid the weak points of current cry-
stallization protocols. The idea is to build DNA assembled molecules into ca-
ges that would contain oriented guest molecules and thus to assist regular
molecular orientation in a 3-D space and grow crystals.
Molecular recognition regarded by many as a recent fashionable concept,
is in fact quite an old mental picture of biological events described by E.
Fischer in 1894109 as »Schlüssel-Schloss-Prinzip« (Key-Lock analogy). E. Fi-
scher's global concept (free of details) on the specificity of enzyme activity
survived a century, and has been one of the most fertile metaphors. It was
used in 1897 by P. Ehrlich110 in the area of immunology and its contempo-
rary vision is one of the best examples of the molecular recognition appro-
ach. E. Fischer was aware of enzyme specificity and built a picture of en-
zyme-substrate interaction, which was verified by examples of the X-ray
structures of numerous enzymes and their complexes with substrates and/or
inhibitors. These X-ray structures have provided essential data for under-
standing the mechanism of biological activity at the atomic level and have
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Figure 13. DNA-based truncated octahedron; a view down the four-fold axis. Each
edge of the polyhedron contains two double helical turns of DNA. The molecule has
14 cyclic strands of DNA and its molecular weight is about 790 000 Da. Legend em-
ployed: each nucleotide is shown with a coloured dot corresponding to a backbone,
and a white dot corresponding to a base. Printed by permission of Prof. dr. N. C.
Seeman.108
led to the design of new drugs. Developments of X-ray analysis have offered
more reliable data on protein structures and their assemblies, and revised
pictures of many biological events. The static lock-key model was expanded
to a dynamic one based on the induced fit theory, illustrated by the hand-
glove analogy.111 It means that in the process of a substrate or inhibitor bind-
ing into an enzyme active site, some conformational adaptations can take
place. Molecular dynamics simulations can evaluate the energy changes of
such processes and identify the most stable conformations.
One of the most striking examples is the three-dimensional structure of
aspartyl protease from human immunodeficiency virus HIV-1 (at 3.0 Å reso-
lution,112 2.7 Å113). This pepsin-like enzyme is the smallest among the retro-
viral proteases with 99 amino acids. The protease is a dimer with a crystal-
lographic two-fold axis through the active site (Figure 14). Quite a number
of complexes with transition state inhibitors and protease mutants were
analysed (Ref. 114 and references therein). The knowledge of these struc-
tures and details of the active site mechanism enabled the design of specific
inhibitors; some of them have become new anti-HIV drugs. This research
has contributed significantly to the decrease in the number of fatal cases, by
two thirds during the past ten years (Figure 15). Knowledge of an enzyme
structure is also a prerequisite for site-specific mutagenesis, which might be
used in gene therapy. Structure-based drug design depends on the target
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Figure 14. The HIV-1 aspartyl protease appears as the active dimer with a crystallo-
graphic two-fold axis.113,114 The active site is shown with an inhibitor. The picture
was obtained from dr. M. A. Navia.
protein, the location of that protein in the host and/or pathogen, the flexibili-
ty of the target protein upon ligand binding, and the nature of the site to
which these compounds have to bind. The combination of X-ray analyses
and molecular modelling,115,116 supported by molecular genetics including
the proteomics approach (protein genomics),117 in the search for new drugs
has become a standard procedure employed in pharmaceutical industry.
Methods of contemporary crystallography are capable of probing deeply
into cell biology events, e.g. in an attempt to elucidate the structure of the
bacterial ribosome (weight of 2.6 million Da, consisting of two thirds of RNA
and one third of proteins), the factory in the cell cytoplasm that makes pro-
teins.30–42 For about 40 years, research has been focused on the structures
of the bacterial ribosome components. The resolution of the crystal struc-
ture electron density of the 50S ribosome subunit (at 2.4 Å) (Figure
16)31,37,40,41 reveals a new fact about the ribosome function, which enables to
propose the mechanism of the peptide synthesis catalysed by ribosome; ac-
tually, the ribosome is a ribozyme.41,42 These, among the largest asymmetric
objects ever determined by X-ray crystallography, are: 30S (900 kDa),32,36,118,119
50S (1600 kDa),31,37,40,41 and 70S (2500 kDa, Refs. 33, 34 and references
therein). These structures have been essential for establishing the location
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Figure 15. Diagram illustrating the reduction of fatal cases of AIDS-patients after
discovery of the structure and function of aspartic HIV-1 protease, which enabled de-
sign of its inhibitors serving as useful drugs (copied from http://www.cdc.gov./hiv/gra-
phics/mortalit.htm).
of the 54 proteins and more than 4500 nucleotides of RNA and their relative
positions and functions within the global ribosome unit. Cryo-electron micro-
scopy120–122 has also contributed significantly to the mapping of the ribosome
particle and to the location of the heavy atom sites required for phasing
structure factors.
Among the high achievements of cryo-electron microscopy with regard to
structure elucidations are the dazzling examples of the lipid-containing (ds)
DNA viruses: Chilo iridescent and Paramecium bursaria chlorela viruses of
about 1900 Å in diameters. Both have a size of about 1 GDa with character-
istic icosahedral symmetry.123
PROSPECTS
»As everyone knows, long-term predictions in science are hopeless and
even short-term predictions are usually wrong«.124 One might quote Daniel
Kleppner's words dedicated to the 50th anniversary of Physics Today (1998)
and skip this last paragraph. However, one can expect that scientists will
continue to make new discoveries that will take away our breath and widen
our horizons. On the basis of the results achieved, one can try to predict the
most promising research lines.
Cryo-electron microscopy,125,126 time-resolved crystallography,68,69 protein
crystallography with fourth-generation synchrotrons, and computer model-
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Figure 16. »Crown« view of the 50S subunit of ribosome with ribbon representations
of protein and RNA-fragment structures; identified units are labeled.31,40,41 The pic-
ture was obtained from dr. N. Ban.
ling are on the way to reveal dynamic pictures of crucial living-cell pro-
cesses. Elucidating the mechanism of protein synthesis in the ribosome
means getting closer to understanding how cells are capable of controlling
the ongoing processes, and to prevent mistakes or to correct them. Cells
must avoid misfolded or incorrectly assembled proteins, because only the
correct ones should travel further to their site of action. It is obvious that,
knowing the mechanisms at the molecular level, one can try to solve the
problems in pathological and degenerative processes such as Alzheimer and
Kreuzfeld-Jacob's diseases, cancer, and ageing. Molecular medicine will be
more and more oriented towards gene therapy.
It is certain that the human genome project14 and the many recently
completed genome sequences of several microorganisms and three plants
will keep protein crystallographers busy for quite a long period ahead. The
Drosophila melangaster (fruit fly) genome sequencing can be added to this
list.127,128 Its cell biology and development have much in common with
mammals and »this sequence may be the Rosetta stone for deciphering the
human genome«.129 Envisaging the solving of protein structures related to
the human genome requires special tactics and a selection list of core pro-
teins has to be made for X-ray crystallography. The priority list has been a
topic of intense discussion among scientists. Whatever we may say about
the impact of the human genome project on the life sciences and humanity
in general may sound like science fiction.
The accumulation of known protein structures will enable us to estab-
lish more precisely the structure-function correlations, which will be used in
drug design and biotechnology. It will also be possible to apply mutagenesis
even more precisely. Looking into chemically analogous enzyme mechanisms
of various species (from bacteria to mammals) at the molecular level, we
will learn more about the biological evolution and Darwin's theory.
Definitely, the numerous new fields offer great challenges to the new ge-
neration of scientists to discover the secrets of Nature and to use them to
the benefit of human beings.
The prediction of the crystal and molecular structures of small mole-
cules and of the secondary structures of proteins (protein folding) can be
viewed as the study of a complex organizational problem,130 but prediction
will become more routine and accurate in the future. Being a good »prophet«
in structure predictions means finding a solution of the global free energy
minimum for the system studied. The potential energy of the molecule or its
assembly depends on the topological arrangement of the atoms and has to
be optimized. Thus, the complexity of the nontrivial global optimization pro-
blem increases for large systems, but parallel computers and efficient meth-
ods and their combinations (simulated annealing, hypersurface deformation
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approach, molecular dynamics simulations, genetic algorithms and modifi-
cations) are very promising. For further improvements of algorithms and
potential energy functions, more accurate structural data need to be extrac-
ted from structural databases. The enormous potential of protein folding
studies does not only concern secondary structure predictions but also dyna-
mics, equally applicable to real and to theoretical systems at femto seconds
and even further. These studies will reveal how simple concepts can emerge
from complex systems.
How it can be that mathematics, being after all
a product of human thought independent of experience,
is so admirably adapted to the objects of reality.
A. Einstein
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SA@ETAK
(Bio)kristalografija na prijelomu tisu}lje}a
Biserka Koji}-Prodi} i Jan Kroon
Prikaz je usmjeren na suvremenu ulogu rentgenske kristalografije i njezin utje-
caj na kemiju i znanosti o `ivotu. Otkri}e strukture dvostruke zavojnice DNK iz dija-
grama vlakna 1953. ozna~ilo je proteklo stolje}e, a projekt ljudskog genoma (koji }e
biti dovr{en 2003. na 50. godi{njicu otkri}a Cricka i Watsona) i proteomici, otvorit }e
novo tisu}lje}e. Odre|ivanje kristalnih struktura ~ak i slo`enih biolo{kih agregata,
kao {to su virusi i ribosomi, ilustriraju snagu dana{nje rentgenske strukturne analize.
U prikazu povijesne osnove dodirnute su neke od va`nih etapa, po~ev{i od samog
otkri}a rentgenskih zraka. Usavr{ene, nove metode i tehnologije modernog vremena
– kao {to su sinkrotroni tre}e generacije, osjetljivi detektori, suvremena ra~unalska
grafika, kriotehnike, metode mikrokristalizacije i geneti~ko in`enjerstvo – doprinos
su razvoju rentgenske kristalografije, {to je opisano u posebnom poglavlju. Primjeri
koji predo~uju snagu metode odabrani su iz aktualnog istra`ivanja podru~ja. Siste-
matika poznatih struktura »malenih« i makro-molekula te njihovih agregata, izgra|i-
vana godinama, uve}ala je na{e znanje o kemijskoj vezi i me|udjelovanjima atoma i
molekula, koja odre|uju kemijska, fizikalna i biolo{ka svojstva. Takve osnovne spoznaje
34 B. KOJI]-PRODI] AND J. KROON
omogu}uju predvi|anje struktura i svojstava molekula {to se pokazalo korisnim u
mnogim podru~jima znanosti i tehnologije. Metoda je krenula sa strukturom kuhinjske
soli, a razvila se u vrlo fini pribor za gledanje unutra{njosti slo`enih `ivih sustava.
Kristalografija vezana uz pra}enje strukturnih promjena u vremenu i krioelektronska
mikroskopija mogu bilje`iti biolo{ke procese i obavijestiti nas o dinamici enzima i o
aktivnostima `ivih stanica. Zahvaljuju}i bioinformatici vrlo brzi doga|aji – zabilje`eni
eksperimentalno ili pretpostavljeni teorijski – mogu se interpretirati simulacijama
molekulske dinamike. Veoma intenzivno pro`imanje ideja iz razli~itih znanstvenih
podru~ja i tehnologija dovodi do kapitalnih otkri}a koja otvaraju putove novim dis-
ciplinama kao {to su molekulska genetika i molekulska medicina. Potonje dvije gra-
ne, oboga}ene otkri}em struktura DNK i proteina, mogu ponuditi efikasne terapije
za mnoge bolesti, o~uvanje zdravlja i ubla`iti probleme starenja. Na{i pogledi na pri-
rodu kemijske veze mijenjaju se, i na{i }e se vidici pro{iriti i postati jasniji u godi-
nama koje dolaze. Po{tuju}i eti~ke principe u znanosti, ~ovje~anstvo }e nau~iti kako
pobolj{ati kvalitetu `ivota svim stanovnicima Zemlje.
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